angiotensin-converting enzyme inhibitors

Preferred Label : angiotensin-converting enzyme inhibitors;

MeSH definition : A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.;

MeSH synonym : enzyme antagonists, angiotensin-converting; inhibitors, kininase ii; antagonists, angiotensin-converting enzyme; ace inhibitors; angiotensin i-converting enzyme inhibitors; kininase ii inhibitors; angiotensin-converting enzyme antagonists; antagonists, kininase ii; kininase ii antagonists; antagonists, angiotensin converting enzyme; angiotensin i converting enzyme inhibitors; enzyme inhibitors, angiotensin-converting; inhibitors, angiotensin converting enzyme; inhibitors, angiotensin-converting enzyme; angiotensin converting enzyme antagonists; inhibitors, ace; angiotensin converting enzyme inhibitors; Kininase II Inhibitor; II Inhibitor, Kininase; Inhibitor, Kininase II; Angiotensin Converting Enzyme Inhibitor; ACE Inhibitor; Inhibitor, ACE; Angiotensin I-Converting Enzyme Inhibitor; Angiotensin I Converting Enzyme Inhibitor; Angiotensin-Converting Enzyme Inhibitor; Enzyme Inhibitor, Angiotensin-Converting; Inhibitor, Angiotensin-Converting Enzyme;

MeSH annotation : protease inhib & antihypertensives; DF: ACE INHIB;

Wikipedia link : https://en.wikipedia.org/wiki/ACE inhibitor;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000806;

UMLS CUI

C0003015;

ATC code(s)
- ACE inhibitors, other combinations [ATC Code]
- ace inhibitors and calcium channel blockers [ATC Code]
- ace inhibitors and diuretics [ATC Code]
- ace inhibitors, combinations [ATC Code]
- ace inhibitors, plain [ATC Code]
- ace inhibitors, plain [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Imidapril [Bloc CIM-11]
- Poisoning caused by angiotensin-converting-enzyme inhibitors (disorder) [SNOMED CT concept]
- Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance) [SNOMED CT concept]
False automatic mappings
- Angiotensin-converting-enzyme inhibitors [ICD-10 Sub-category (who)]
- Angiotensin-converting-enzyme inhibitors [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors [ICD-10 Sub-category]
Indexing information
- (E)-1-oxo-3,4-dihydro-1H-isochromen-7-yl 3-(3,4-dihydroxyphenyl)acrylate [MeSH Supplementary Concept]
- 2-((3-(hydroxyl(2-phenyl-1-(((benzyloxy)carbonyl)amino)ethyl)phosphinyl)-2-((3-phenylisoxazol-5-yl)methyl)-1-oxo-propyl)amino)-3-(4-hydroxy-phenyl)propanoic acid [MeSH Supplementary Concept]
- 7,8-dihydroxy-3-methyl-isochromanone-4 [MeSH Supplementary Concept]
- ACE-ECE-1 dual inhibitor FI [MeSH Supplementary Concept]
- DX600 peptide [MeSH Supplementary Concept]
- NWT-03 [MeSH Supplementary Concept]
- SR 40037 [MeSH Supplementary Concept]
- glutaminyl-isoleucyl-glycyl-leucyl-phenylalanine [MeSH Supplementary Concept]
- isoleucyl-prolyl-proline [MeSH Supplementary Concept]
- valyl-prolyl-proline [MeSH Supplementary Concept]
- zanipress [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- Peptidyl-Dipeptidase A [MeSH Descriptor]
Metaterm(s)
- cardiology [CISMeF Metaterm]
Record concept(s)
- Angiotensin-Converting enzyme inhibitors [MeSH concept]
SNOMED CT : is a
- captopril [MeSH Descriptor]
- cilazapril [MeSH Descriptor]
- enalapril [MeSH Descriptor]
- enalaprilat [MeSH Descriptor]
- fosinopril [MeSH Descriptor]
- lisinopril [MeSH Descriptor]
- perindopril [MeSH Descriptor]
- ramipril [MeSH Descriptor]
See also
- angiotensin II type 1 receptor blockers [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
- renin-angiotensin system [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (S)-malic acid 1'-O-beta-gentiobioside [MeSH Supplementary Concept]
- 1-sarcosine-8-isoleucine angiotensin ii [MeSH Descriptor]
- 2-(2-(5-bromoindan-1-yl)-3-mercaptopropionylamino)-3-(1H-pyrrolo(2,3-b)pyridin-3-yl)propionic acid [MeSH Supplementary Concept]
- 7-((2-(acetylthio)-1-oxo-3-methylpropyl)amino)-1,2,3,4,6,7,8,12b-octahydro-6-oxopyrido(2,1-a)(2)benzazepin-4-carboxyacid [MeSH Supplementary Concept]
- IRW peptide [MeSH Supplementary Concept]
- L-proline, N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl- [MeSH Supplementary Concept]
- LVV-hemorphin 6 [MeSH Supplementary Concept]
- N-((1-((2-(acetylthio)-3-methyl-1-oxobutyl)amino)-1-cyclopentyl)carbonyl)-O-methyl-L-tyrosine ethyl ester [MeSH Supplementary Concept]
- N-(1-carboxy-3-phenylpropyl)-alanylalanine [MeSH Supplementary Concept]
- N-(2-(mercaptomethyl)-3-methylbutanoyl)-4-(1H-pyrazol-1-yl)phenylalanine [MeSH Supplementary Concept]
- Quinapril [MeSH Descriptor]
- alacepril [MeSH Supplementary Concept]
- benazepril [MeSH Supplementary Concept]
- benazeprilat [MeSH Supplementary Concept]
- captopril [MeSH Descriptor]
- captopril, hydrochlorothiazide drug combination [MeSH Supplementary Concept]
- ceronapril [MeSH Supplementary Concept]
- cilazapril [MeSH Descriptor]
- cilazaprilat [MeSH Supplementary Concept]
- delapril [MeSH Supplementary Concept]
- enalapril [MeSH Descriptor]
- enalaprilat [MeSH Descriptor]
- fosinopril [MeSH Descriptor]
- fosinoprilat [MeSH Supplementary Concept]
- glyceraldehyde 3-phosphate dehydrogenase (304-313) [MeSH Supplementary Concept]
- imidapril [MeSH Supplementary Concept]
- imidaprilat [MeSH Supplementary Concept]
- libenzapril [MeSH Supplementary Concept]
- lisinopril [MeSH Descriptor]
- moexipril [MeSH Supplementary Concept]
- perindopril [MeSH Descriptor]
- perindoprilat [MeSH Supplementary Concept]
- quinaprilat [MeSH Supplementary Concept]
- ramipril [MeSH Descriptor]
- ramiprilat [MeSH Supplementary Concept]
- rentiapril [MeSH Supplementary Concept]
- saralasin [MeSH Descriptor]
- spirapril [MeSH Supplementary Concept]
- temocapril hydrochloride [MeSH Supplementary Concept]
- teprotide [MeSH Descriptor]
- trandolapril [MeSH Supplementary Concept]
- valyl-prolyl-proline [MeSH Supplementary Concept]
- zofenopril [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- ACE Inhibitor [NCIt concept]
- ACE inhibitor [Radlex concept]
- ACE inhibitor [LOINC part]
- Ace inhibitors [LOINC hierarchical part]
- Angiotensin-converting-enzyme inhibitors [ICD-10 Sub-category (who)]
- Angiotensin-converting-enzyme inhibitors [ICD-11 Extension code]
- Imidapril [Bloc CIM-11]
- Product containing angiotensin-converting enzyme inhibitor (product) [SNOMED CT concept]
- Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance) [SNOMED CT concept]
- angiotensin-converting enzyme inhibitor agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients